Westside Investment Management, Inc. Catalent, Inc. Transaction History

Westside Investment Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 20, 2024	SELL	$56.16 - $60.96 $12,074 - $13,106	-215 Reduced 1.15%	18,448 $1.12 Billion
Q2 2024 Jul 17, 2024	SELL	$53.58 - $57.02 $19,288 - $20,527	-360 Reduced 1.89%	18,663 $1.05 Billion
Q1 2024 Apr 19, 2024	SELL	$42.56 - $59.82 $95,760 - $134,595	-2,250 Reduced 10.58%	19,023 $1.07 Billion
Q4 2023 Jan 12, 2024	BUY	$32.18 - $46.57 $85,277 - $123,410	2,650 Added 14.23%	21,273 $956 Million
Q3 2023 Nov 15, 2023	SELL	$44.2 - $50.2 $41,990 - $47,690	-950 Reduced 4.85%	18,623 $848 Million
Q2 2023 Jul 14, 2023	BUY	$31.86 - $67.26 $162,167 - $342,353	5,090 Added 35.14%	19,573 $849 Million
Q1 2023 May 17, 2023	SELL	$45.44 - $74.26 $75,748 - $123,791	-1,667 Reduced 10.32%	14,483 $952 Million
Q4 2022 Jan 31, 2023	BUY	$41.39 - $81.0 $668,448 - $1.31 Million	16,150 New	16,150 $726,000

422

147M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Westside Investment Management, Inc. with notifications on news.